SPY330.65-3.85 -1.15%
DIA276.52-2.38 -0.85%
IXIC10,793.28-117.00 -1.07%

X4 Pharmaceuticals Q1 EPS $(0.560) Beats $(0.800) Estimate

X4 Pharmaceuticals (NASDAQ:XFOR) reported quarterly losses of $(0.560) per share which beat the analyst consensus estimate of $(0.800) by 30 percent.

Benzinga · 05/07/2020 11:49

X4 Pharmaceuticals (NASDAQ:XFOR) reported quarterly losses of $(0.560) per share which beat the analyst consensus estimate of $(0.800) by 30 percent.